Literature DB >> 24412275

Is synaptic loss a unique hallmark of Alzheimer's disease?

Stephen W Scheff1, Janna H Neltner2, Peter T Nelson3.   

Abstract

Synapses may represent a key nidus for dementia including Alzheimer's disease (AD) pathogenesis. Here we review published studies and present new ideas related to the question of the specificity of synapse loss in AD. Currently, AD is defined by the regional presence of neuritic plaques and neurofibrillary tangles in the brain. The severity of involvement by those pathological hallmarks tends to correlate both with antemortem cognitive status, and also with synapse loss in multiple brain areas. Recent studies from large autopsy series have led to a new standard of excellence with regard to clinical-pathological correlation and to improved comprehension of the numerous brain diseases of the elderly. These studies have provided evidence that it is the rule rather than the exception for brains of aged individuals to demonstrate pathologies (often multiple) other than AD plaques and tangles. For many of these comorbid pathologies, the extent of synapse loss is imperfectly understood but could be substantial. These findings indicate that synapse loss is probably not a hallmark specific to AD but rather a change common to many diseases associated with dementia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebrovascular; HS-Aging; Hippocampal sclerosis; Neuropathology; TDP-43

Mesh:

Year:  2014        PMID: 24412275      PMCID: PMC4230706          DOI: 10.1016/j.bcp.2013.12.028

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  164 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.

Authors:  Rudi K Tannenberg; Heather L Scott; Anthony E G Tannenberg; Peter R Dodd
Journal:  Neurochem Int       Date:  2006-06-30       Impact factor: 3.921

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Absence of cognitive impairment or decline in preclinical Alzheimer's disease.

Authors:  W P Goldman; J L Price; M Storandt; E A Grant; D W McKeel; E H Rubin; J C Morris
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

Review 5.  Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.

Authors:  D Allan Butterfield; Marzia Perluigi; Rukhsana Sultana
Journal:  Eur J Pharmacol       Date:  2006-06-15       Impact factor: 4.432

6.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

7.  Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein.

Authors:  Geneviève Leuba; Armand Savioz; André Vernay; Béatrice Carnal; Rudolf Kraftsik; Eric Tardif; Irène Riederer; Béat Michel Riederer
Journal:  J Alzheimers Dis       Date:  2008-09       Impact factor: 4.472

8.  Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Kelly N Roberts; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Neuropathology and general autopsy findings in nondemented aged subjects.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Clin Neuropathol       Date:  2012 Mar-Apr       Impact factor: 1.368

Review 10.  Role of cerebral cortex in the neuropathology of Huntington's disease.

Authors:  Ana M Estrada-Sánchez; George V Rebec
Journal:  Front Neural Circuits       Date:  2013-02-18       Impact factor: 3.492

View more
  51 in total

1.  Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Mubeen A Ansari; Kelly N Roberts; Frederick A Schmitt; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.

Authors:  Corinne Pettigrew; Anja Soldan; Abhay Moghekar; Mei-Cheng Wang; Alden L Gross; Richard O'Brien; Marilyn Albert
Journal:  Neuropsychologia       Date:  2015-09-21       Impact factor: 3.139

3.  Beneficial Effects of Exercise Pretreatment in a Sporadic Alzheimer's Rat Model.

Authors:  Chongyun Wu; Luodan Yang; Donovan Tucker; Yan Dong; Ling Zhu; Rui Duan; Timon Cheng-Yi Liu; Quanguang Zhang
Journal:  Med Sci Sports Exerc       Date:  2018-05       Impact factor: 5.411

Review 4.  Cellular prion protein: A co-receptor mediating neuronal cofilin-actin rod formation induced by β-amyloid and proinflammatory cytokines.

Authors:  Keifer P Walsh; Thomas B Kuhn; James R Bamburg
Journal:  Prion       Date:  2014       Impact factor: 3.931

Review 5.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

6.  Brain pathologies in extreme old age.

Authors:  Janna H Neltner; Erin L Abner; Gregory A Jicha; Frederick A Schmitt; Ela Patel; Leonard W Poon; Gearing Marla; Robert C Green; Adam Davey; Mary Ann Johnson; S Michal Jazwinski; Sangkyu Kim; Daron Davis; John L Woodard; Richard J Kryscio; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

7.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

8.  Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Authors:  Stephen W Scheff; Mubeen A Ansari; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

9.  Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.

Authors:  Ming-Kai Chen; Adam P Mecca; Mika Naganawa; Sjoerd J Finnema; Takuya Toyonaga; Shu-Fei Lin; Soheila Najafzadeh; Jim Ropchan; Yihuan Lu; Julia W McDonald; Hannah R Michalak; Nabeel B Nabulsi; Amy F T Arnsten; Yiyun Huang; Richard E Carson; Christopher H van Dyck
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

10.  Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease.

Authors:  Pamela V Martino Adami; Celia Quijano; Natalia Magnani; Pablo Galeano; Pablo Evelson; Adriana Cassina; Sonia Do Carmo; María C Leal; Eduardo M Castaño; A Claudio Cuello; Laura Morelli
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-09       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.